Healthcare Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Industry Today.

Press releases published on June 1, 2026

Jun. 1, 2026

Allocetra Shows Durable 6-Month Efficacy in Knee Osteoarthritis Phase IIa Trial; Oral Presentation at EULAR 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Cytokinetics Launches MYQORZO® (aficamten) in European Union, with First Commercial Availability in Germany

Indeterminate GlobeNewswire

Jun. 1, 2026

Intellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral Presentation at EAACI 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York

Indeterminate GlobeNewswire

Jun. 1, 2026

Vireo Growth Inc. Announces Share Consolidation

Indeterminate GlobeNewswire

Jun. 1, 2026

Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Cancer Patients at ASCO

Indeterminate GlobeNewswire

Jun. 1, 2026

Cognition Therapeutics Participating in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Jun. 1, 2026

TG Therapeutics Announces Publication of Post-Hoc Data from the Phase 3 ULTIMATE I & II Trials in Treatment Naive Patients with Relapsing Forms of MS Published in Frontiers in Immunology

Indeterminate GlobeNewswire

Jun. 1, 2026

BriaCell Presents Positive Clinical Data at ASCO 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

TechForce Robotics Enters Pharmaceutical Automation Market Through Initial Deployment at Oncotelic Therapeutics

Indeterminate GlobeNewswire

Jun. 1, 2026

Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001

Indeterminate GlobeNewswire

Jun. 1, 2026

Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID

Indeterminate GlobeNewswire

Jun. 1, 2026

Nouscom Receives U.S. FDA Fast Track Designation for NOUS-209, a Novel Immunotherapy for the Prevention of Lynch Syndrome-Associated Cancers

Indeterminate GlobeNewswire

Jun. 1, 2026

Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking

Indeterminate GlobeNewswire

Jun. 1, 2026

Lungpacer Medical Appoints Steven Pfanstiel as Chief Financial Officer

Indeterminate GlobeNewswire

Jun. 1, 2026

Verano Announces 1-for-5 Reverse Stock Split to Prepare the Company for Prospective U.S. Stock Exchange Listing

Indeterminate GlobeNewswire

Jun. 1, 2026

Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy

Indeterminate GlobeNewswire

Jun. 1, 2026

Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer

Indeterminate GlobeNewswire

Jun. 1, 2026

Syndax to Host R&D Day Highlighting its Late-Stage Programs and Early-Stage Assets on July 14, 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Jade Biosciences Announces Positive Interim Phase 1 Results for JADE101 Demonstrating Potential Best-in-Class Profile and Every-12-Week Dosing in IgA Nephropathy

Indeterminate GlobeNewswire